NRF2-driven transcription and KEAPness predict survival outcomes in lung cancer treated with immunotherapy
Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Beatrice Messina, Giulia Schiavoni, Alessandro Di Federico, Joao V. Alessi, Maurizio Fanciulli, Ludovica Ciuffreda, Francesca De Nicola, Frauke Goeman, Giulio Caravagna, Daniele Santini, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Mariam Jamal-Hanjani, Mark M. Awad, Nicholas McGranahan, Marcello Maugeri-Saccà
medRxiv 2023.10.30.23297743; doi: https://doi.org/10.1101/2023.10.30.23297743